Extra-intestinal calcium handling contributes to normal serum calcium levels when intestinal calcium absorption is suboptimal. 2015

Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
Laboratory of Clinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium.

The active form of vitamin D, 1,25(OH)2D, is a crucial regulator of calcium homeostasis, especially through stimulation of intestinal calcium transport. Lack of intestinal vitamin D receptor (VDR) signaling does however not result in hypocalcemia, because the increased 1,25(OH)2D levels stimulate calcium handling in extra-intestinal tissues. Systemic VDR deficiency, on the other hand, results in hypocalcemia because calcium handling is impaired not only in the intestine, but also in kidney and bone. It remains however unclear whether low intestinal VDR activity, as observed during aging, is sufficient for intestinal calcium transport and for mineral and bone homeostasis. To this end, we generated mice that expressed the Vdr exclusively in the gut, but at reduced levels. We found that ~15% of intestinal VDR expression greatly prevented the Vdr null phenotype in young-adult mice, including the severe hypocalcemia. Serum calcium levels were, however, in the low-normal range, which may be due to the suboptimal intestinal calcium absorption, renal calcium loss, insufficient increase in bone resorption and normal calcium incorporation in the bone matrix. In conclusion, our results indicate that low intestinal VDR levels improve intestinal calcium absorption compared to Vdr null mice, but also show that 1,25(OH)2D-mediated fine-tuning of renal calcium reabsorption and bone mineralization and resorption is required to maintain fully normal serum calcium levels.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002136 Calcium, Dietary Calcium compounds in DIETARY SUPPLEMENTS or in food that supply the body with calcium. Dietary Calcium
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell

Related Publications

Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
December 1968, Clinical chemistry,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
August 2010, Bone,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
July 2015, Nutrition journal,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
May 1969, Metabolism: clinical and experimental,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
August 1972, Annals of internal medicine,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
February 2004, European journal of clinical nutrition,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
May 2021, Comprehensive Physiology,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
February 2001, Clinical calcium,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
July 1967, Comparative biochemistry and physiology,
Liesbet Lieben, and Lieve Verlinden, and Ritsuko Masuyama, and Sophie Torrekens, and Karen Moermans, and Luc Schoonjans, and Peter Carmeliet, and Geert Carmeliet
March 1992, The Journal of nutrition,
Copied contents to your clipboard!